GlassScriptPhysician profile
Candice Geary
NPI 1639286784
$2,470.89
in general payments reported to CMS, 2019-2025
30 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $369 · 2020: $219 · 2021: $543 · 2022: $856 · 2023: $485.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $485.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $485.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $378.81 | 2019-2023 | |
| Astellas Pharma US INC | $360.20 | 2019-2023 | Veozah, Myrbetriq |
| Daiichi Sankyo INC. | $263.92 | 2020-2023 | Injectafer |
| Myovant Sciences INC. | $150.28 | 2021-2022 | |
| Novo Nordisk INC | $145.78 | 2023 | Wegovy |
| Hologic Sales and Service, LLC | $143.83 | 2019-2022 | |
| Minerva Surgical, INC | $127.27 | 2019-2022 | |
| Exeltis, USA INC. | $116.57 | 2021-2023 | Slynd |
| Amgen INC. | $98.78 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $96.10 | 2022-2023 | |
| Pfizer INC. | $95.83 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $58.81 | 2019-2023 | |
| Organon LLC | $55.43 | 2021-2023 | Nexplanon |
| Therapeuticsmd, INC. | $53.57 | 2019-2021 | |
| Urovant Sciences INC | $34.45 | 2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $32.65 | 2019 | |
| Scynexis, INC. | $32.47 | 2022 | |
| Ascend Therapeutics US, LLC | $24.49 | 2021 | |
| Ethicon US, LLC | $23.41 | 2019 | |
| Lilly USA, LLC | $23.14 | 2023 | Zepbound |
| Coopersurgical, INC. | $22.62 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $21.14 | 2023 | Myfembree |
| Convatec INC. | $16.84 | 2021 | |
| Vertical Pharmaceuticals, LLC | $16.41 | 2019 | |
| Teleflex LLC | $16.12 | 2020 | |
| Virtus Pharmaceuticals LLC | $15.36 | 2021 | |
| Avion Pharmaceuticals | $13.17 | 2023 | Balcoltra |
| Merck Sharp & Dohme LLC | $12.08 | 2019 | |
| Glaxosmithkline, LLC. | $11.71 | 2019 | |
| Meditrina | $9.65 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Candice Geary listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.